SARS-CoV-2


Journal

PeerJ
ISSN: 2167-8359
Titre abrégé: PeerJ
Pays: United States
ID NLM: 101603425

Informations de publication

Date de publication:
2023
Historique:
received: 14 10 2022
accepted: 24 02 2023
medline: 11 4 2023
entrez: 10 4 2023
pubmed: 11 4 2023
Statut: epublish

Résumé

Understanding the interactions between SARS-CoV-2 and host cell machinery may reveal new targets to treat COVID-19. We focused on an interaction between the SARS-CoV-2 ORF3A accessory protein and the CLIC-like chloride channel-1 (CLCC1). We found that ORF3A partially co-localized with CLCC1 and that ORF3A and CLCC1 could be co-immunoprecipitated. Since CLCC1 plays a role in the unfolded protein response (UPR), we hypothesized that ORF3A may also play a role in the UPR. Indeed, ORF3A expression triggered a transcriptional UPR that was similar to knockdown of

Identifiants

pubmed: 37033725
doi: 10.7717/peerj.15077
pii: 15077
pmc: PMC10078464
doi:

Substances chimiques

Chloride Channels 0
CLCC1 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e15077

Subventions

Organisme : NIDDK NIH HHS
ID : U24 DK116214
Pays : United States

Informations de copyright

©2023 Gruner et al.

Déclaration de conflit d'intérêts

The authors declare there are no competing interests.

Références

Biol Cell. 2021 Jul;113(7):311-328
pubmed: 33666950
J Comput Biol. 2013 Dec;20(12):970-8
pubmed: 23961961
J Neurosci. 2015 Feb 18;35(7):3001-9
pubmed: 25698737
Cell Metab. 2012 Aug 8;16(2):250-64
pubmed: 22883233
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Genet. 2000 May;25(1):25-9
pubmed: 10802651
Cell Metab. 2012 Aug 8;16(2):265-73
pubmed: 22883234
Hum Mol Genet. 2012 Mar 1;21(5):963-77
pubmed: 22045699
Int J Mol Sci. 2020 Sep 03;21(17):
pubmed: 32899231
Nat Commun. 2021 Sep 20;12(1):5536
pubmed: 34545074
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
PLoS One. 2009 Dec 17;4(12):e8342
pubmed: 20020050
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Nat Protoc. 2016 Sep;11(9):1650-67
pubmed: 27560171
Neurochem Res. 2018 Feb;43(2):340-350
pubmed: 29090408
J Biol Chem. 2012 Sep 14;287(38):31994-2005
pubmed: 22854956
J Gen Virol. 2005 Jul;86(Pt 7):1921-1930
pubmed: 15958670
Cell. 2001 Dec 28;107(7):881-91
pubmed: 11779464
Signal Transduct Target Ther. 2021 Mar 15;6(1):123
pubmed: 33723219
Cell. 2020 Aug 6;182(3):685-712.e19
pubmed: 32645325
Sci Rep. 2021 Aug 25;11(1):17146
pubmed: 34433867
PLoS Genet. 2018 Aug 29;14(8):e1007504
pubmed: 30157172
J Biol Chem. 2001 Jun 8;276(23):20413-8
pubmed: 11279057
IUBMB Life. 2022 Jan;74(1):93-100
pubmed: 34390301
Nucleic Acids Res. 2019 Jan 8;47(D1):D419-D426
pubmed: 30407594
FASEB J. 2019 Aug;33(8):8865-8877
pubmed: 31034780
Nucleic Acids Res. 2019 Jan 8;47(D1):D330-D338
pubmed: 30395331
Science. 2013 Feb 15;339(6121):823-6
pubmed: 23287722
Cell Mol Immunol. 2020 Aug;17(8):881-883
pubmed: 32555321
Dev Cell. 2021 Feb 22;56(4):427-442.e5
pubmed: 33422265
J Virol. 2010 Jan;84(2):1097-109
pubmed: 19889773
J Virol. 2021 Aug 10;95(17):e0040221
pubmed: 34133899
Mol Cell Biol. 2006 Dec;26(24):9220-31
pubmed: 17030611
J Biol Chem. 2017 Dec 8;292(49):19952-19958
pubmed: 29084849
Nature. 2002 Jan 3;415(6867):92-6
pubmed: 11780124
Annu Rev Pathol. 2015;10:173-94
pubmed: 25387057
FEBS Lett. 2015 Jun 4;589(13):1450-8
pubmed: 25957766

Auteurs

Hannah N Gruner (HN)

Diabetes Center, University of California, San Francisco, CA, United States of America.

Yaohuan Zhang (Y)

Diabetes Center, University of California, San Francisco, CA, United States of America.
Metabolic Biology Graduate Program, University of California, Berkeley, CA, United States of America.

Kaavian Shariati (K)

Diabetes Center, University of California, San Francisco, CA, United States of America.

Nicholas Yiv (N)

Diabetes Center, University of California, San Francisco, CA, United States of America.

Zicheng Hu (Z)

Bakar Computational Health Sciences Institute, University of California, San Francisco, CA, United States of America.

Yuhao Wang (Y)

Diabetes Center, University of California, San Francisco, CA, United States of America.

J Fielding Hejtmancik (JF)

National Eye Institute, Bethesda, MD, United States of America.

Michael T McManus (MT)

Diabetes Center, University of California, San Francisco, CA, United States of America.

Kevin Tharp (K)

Center for Bioengineering and Tissue Regeneration, University of California, San Francisco, CA, United States of America.

Gregory Ku (G)

Diabetes Center, University of California, San Francisco, CA, United States of America.
Division of Endocrinology and Metabolism, University of California, San Francisco, CA, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH